Archive for June 13, 2022
Today, the U.S. Food and Drug Administration approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a disorder that often appears…
Tags
Animal & Veterinary
Award
Biologics
Coronavirus
Cosmetics
Dietary Supplements
Drugs
Follow @FDAmedia on Twitter
Follow @FDAMedia on X
Follow @US_FDA on Twitter
Follow @US_FDA on X
Follow FDA on Facebook
Food & Beverages
Infant Formula & Foods
Infectious Disease
Medical Devices
Office
Over-the-Counter Drugs
Press Announcements
Tobacco
Training
Vaccines

